CN Stock MarketDetailed Quotes

600062 China Resources Double-Crane Pharmaceutical

Watchlist
  • 20.55
  • -0.46-2.19%
Market Closed Dec 13 15:00 CST
21.36BMarket Cap15.84P/E (TTM)

China Resources Double-Crane Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

China Resources Double-Crane Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 26, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
2.62B
--
+0.55%
EPS
--
0.34
--
-13.46%
Analyst Rating
Strong Buy

Dec 14, 2024

China Resources Double-Crane Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Apr 26, 20242024/Q12.835B / 2.876B--
Oct 30, 20192019/Q32.541B / 2.364B--
Aug 22, 20192019/Q22.233B / 2.148B--
Apr 27, 20192019/Q12.633B / 1.802B--
DatePeriodRevenue/EstimateEarnings Call
Apr 26, 20242024/Q12.835B / 2.876B--
Oct 30, 20192019/Q32.541B / 2.364B--
Aug 22, 20192019/Q22.233B / 2.148B--
Apr 27, 20192019/Q12.633B / 1.802B--
--------

Unlock Free Earnings Estimates

China Resources Double-Crane Pharmaceutical Earnings Reports

  • Announcement of China Resources Shuanghe on the main operating data for the 1st to 3rd quarter of 2024

    Oct 26 00:00

  • China Resources Shuanghe 2024 Third Quarter Report

    Oct 26 00:00

  • China resources double-crane pharmaceutical 2024 semi-annual report

    Aug 23 00:00

  • China Resources Double-Crane Pharmaceutical 2024 Half-Year Report Summary

    Aug 23 00:00

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    KAYO MOTOR
    834058
    38.58 +29.99%
    Zhejiang Zoenn Design
    300901
    14.86 +20.03%
    Zhejiang Meorient Commerce & Exhibition Inc.
    300795
    22.36 +20.02%
    Fujian Zitian Media Technology
    300280
    22.18 +20.02%
    Zhejiang Prulde Electric Appliance
    301353
    36.46 +20.01%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Dec 14, 2024

    Strong Buy

    • Strong Buy

      80.00%

    • Buy

      20.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Macrobiotic NMN
    Macrobiotic NMN
    Intraday-1.69%
    State-owned Enterprise Reform
    State-owned Enterprise Reform
    Intraday-1.75%
    ShangHai Stock Connect
    ShangHai Stock Connect
    Intraday-1.84%